Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Attention and CES1[original query] |
---|
Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD. Neuropharmacology 2009 Dec 57 (7-8): 731-3. Nemoda Zsofia, Angyal Nora, Tarnok Zsanett, Gadoros Julia, Sasvari-Szekely Mar |
Methylphenidate side effect profile is influenced by genetic variation in the attention-deficit/hyperactivity disorder-associated CES1 gene. Journal of child and adolescent psychopharmacology 2013 Dec 23 (10): 655-64. Johnson Katherine A, Barry Edwina, Lambert David, Fitzgerald Michael, McNicholas Fiona, Kirley Aiveen, Gill Michael, Bellgrove Mark A, Hawi Ziar |
[Response With Methylphenidate to ADHD-Like Symptoms in Pervasive Developmental Disorder: Does CES-1 Enzyme Gene Polymorphism Have a Role?]. Turk psikiyatri dergisi = Turkish journal of psychiatry 2017 28 (2): 89-94. Akyol Ard?ç Ülkü, Ercan Eyüp Sabri, Aygüne? Duygu, Yüce Deniz, Durak Sibel, Kosova Buk |
CES1 and SLC6A2 Genetic Variants As Predictors of Response To Methylphenidate in Autism Spectrum Disorders. Pharmacogenomics and personalized medicine 2022 11 15 951-957. Hernandez Marta H, Bote Valentin, Serra-LLovich Alexandre, Cendros Marc, Salazar Juliana, Mestres Conxita, Guijarro Silvina, Alvarez Aida, Lamborena Cristina, Mendez Iria, Sanchez Bernardo, Hervas Amaia, Arranz Maria |
High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder: A Case Series. Journal of clinical psychopharmacology 2023 10 . Andrie C Westerkamp, Rob Rodrigues Pereira, Vera R Huitema, Ester A M Kouwert, Maja Matic, Ron H N van Schaik, Nieko Punt, Robert A Schoevers, Daan J To |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: